Altuviiio Children's Study Demonstrates Equivalent Outcomes
A yearlong study of the newly approved half-life extender showed no evidence of factor VIII inhibitors.
Source: managedhealthcareexecutive.com
Stay updated with breaking news from Hemlibra Roche. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A yearlong study of the newly approved half-life extender showed no evidence of factor VIII inhibitors.
The new and million-dollar gene treatment make the disease remit almost completely for four or five years. Open investigations now seek a definitive cure